MADRIGAL PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Madrigal Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Madrigal Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 19.9M shares, a 7.67% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 19.9M +1.42M +7.67% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 19.9M +1.59M +8.71% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 21.7M +3.6M +19.9% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 18.5M +1.39M +8.13% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 18.5M +1.36M +7.93% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 18.3M +1.18M +6.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 18.1M +999K +5.84% Dec 31, 2022 10-K 2024-02-28
Q3 2022 17.1M +243K +1.44% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 17.1M +504K +3.04% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 17.1M +1.04M +6.48% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 17.1M +1.6M +10.3% Dec 31, 2021 10-K/A 2023-03-03
Q3 2021 16.9M +1.39M +9.01% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 16.6M +1.16M +7.52% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 16.1M +634K +4.11% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 15.5M +79K +0.51% Dec 31, 2020 10-K 2022-02-24
Q3 2020 15.5M +37.3K +0.24% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 15.4M +11.8K +0.08% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15.4M +12.1K +0.08% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 15.4M +20.1K +0.13% Dec 31, 2019 10-K 2021-02-25
Q3 2019 15.4M +35.8K +0.23% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 15.4M +60.9K +0.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 15.4M +1.17M +8.18% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 15.4M +1.18M +8.3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 15.4M +2.9M +23.2% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 15.4M +2.87M +23% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 14.3M +2.08M +17.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 14.2M +2.28M +19% Dec 31, 2017 10-K 2019-02-27
Q3 2017 12.5M +926K +8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 12.5M -125M -90.9% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 12.2M -126M -91.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 12M +11.8M +6685% Dec 31, 2016 10-K 2018-03-13
Q3 2016 11.6M -126M -91.6% Sep 30, 2016 10-Q/A 2017-03-31
Q2 2016 138M +3.73M +2.79% Jun 30, 2016 10-Q 2016-07-20
Q1 2016 138M +28.7M +26.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 176K -109M -99.8% Dec 31, 2015 10-Q/A 2017-03-31
Q3 2015 138M +28.9M +26.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 134M +32.8M +32.3% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 109M +21.5M +24.6% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 109M +23.9M +28% Dec 31, 2014 10-K 2016-03-15
Q3 2014 109M +39.8M +57.6% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 101M +32.3M +46.7% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 87.6M +18.5M +26.7% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 85.2M +16.3M +23.7% Dec 31, 2013 10-K 2015-03-12
Q3 2013 69.1M +7.22M +11.7% Sep 30, 2013 10-Q 2013-11-04
Q2 2013 69.1M +11.2M +19.5% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 69.1M +11.5M +19.9% Mar 31, 2013 10-Q 2013-04-30
Q4 2012 68.9M +19.4M +39.1% Dec 31, 2012 10-K 2014-03-11
Q3 2012 61.9M +12.4M +25% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 57.8M +8.34M +16.9% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 57.6M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 49.5M +7.45M +17.7% Dec 31, 2011 10-K 2013-03-14
Q3 2011 49.5M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 49.5M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 42.1M Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.